NewGenIvf Group Ltd is a SG-based company operating in Health Care Providers & Services industry. The company employs 76 full-time employees The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy (MRT) In Reproductive, Intrauterine Insemination (IUI), MRT techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular/epididymal sperm aspiration or extraction/percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening, and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The Company’s subsidiary is NewGenIvf Limited.
Follow-Up Questions
NewGenIvf Group Ltd 'in CEO'su kimdir?
Mr. Claudius Tsang 2021 'den beri şirketle birlikte olan NewGenIvf Group Ltd 'in Chairman of the Board 'ıdır.
NIVF hissesinin fiyat performansı nasıl?
NIVF 'in mevcut fiyatı $1.92 'dir, son işlem günde 2.42% increased etti.
NewGenIvf Group Ltd için ana iş temaları veya sektörler nelerdir?
NewGenIvf Group Ltd Health Care endüstrisine ait ve sektör Health Care 'dir
NewGenIvf Group Ltd 'in piyasa değerlemesi nedir?
NewGenIvf Group Ltd 'in mevcut piyasa değerlemesi $3.5M 'dir
